Monday, September 14, 2026

UK Pours Billions Into Health Tech to Become a Life Sciences Superpower

The UK government aims to lead Europe's life sciences by 2030, investing heavily in health data and regulatory reforms to boost growth.

Biosimilar Red Tape Showdown: Patient Groups and Insurers Push Congress to End “Interchangeability” Rules After $56B in Savings

U.S. groups urge Congress to eliminate biosimilar interchangeability regulations, boosting access and reducing costs for Korean firms.

Cash Crunch Emerges as Bigger Threat Than Delisting for South Korea’s Listed Biotech Firms

South Korea's biotech firms face cash shortages amid tightening delisting rules, raising concerns over funding and operational viability.

Tag: historical issues

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.